Other

Increase (Decrease) in Inventories

Neurocrine Biosciences Increase (Decrease) in Inventories decreased by 226.5% to -$4.30M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 352.9%, from $1.70M to -$4.30M.

Analysis

StatementIncome Statement
SectionOther
CategoryEfficiency
SignalContext dependent
VolatilityModerate
First reportedQ1 2015
Last reportedQ1 2026May 5, 2026

How to read this metric

An increase may signal expected demand growth or supply chain bottlenecks, while a decrease might indicate strong sales or inventory optimization efforts.

Detailed definition

Represents the net change in the value of raw materials, work-in-progress, and finished goods held by the company. This...

Peer comparison

Standard metric for manufacturing and industrial firms; essential for evaluating inventory turnover and operational health.

Metric ID: other_increase_decrease_in_inventories

Historical Data

16 periods
 Q3 '21Q4 '21Q1 '22Q3 '22Q1 '23Q2 '23Q3 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value-$2.80M$5.00M-$1.50M$7.70M-$1.80M-$1.60M-$2.90M-$1.10M$5.30M$3.30M$11.60M$1.70M-$2.10M$12.30M$3.40M-$4.30M
QoQ Change+278.6%-130.0%+613.3%-123.4%+11.1%-81.3%+62.1%+581.8%-37.7%+251.5%-85.3%-223.5%+685.7%-72.4%-226.5%
YoY Change+375.0%-20.0%-137.7%+38.9%+431.3%+213.8%+254.5%-139.6%+272.7%-70.7%-352.9%
Range-$4.30M$12.30M
CAGR+12.1%
Avg YoY Growth+78.7%
Median YoY Growth+38.9%
Current Streak2 quarters decline

Frequently Asked Questions

What is Neurocrine Biosciences's increase (decrease) in inventories?
Neurocrine Biosciences (NBIX) reported increase (decrease) in inventories of -$4.30M in Q1 2026.
How has Neurocrine Biosciences's increase (decrease) in inventories changed year-over-year?
Neurocrine Biosciences's increase (decrease) in inventories decreased by 352.9% year-over-year, from $1.70M to -$4.30M.
What does increase (decrease) in inventories mean?
The change in the total value of products and materials the company has in stock.